Fibroblasts derived from human chronic diabetic wounds have a decreased proliferation rate, which is recovered by the addition of heparin
Journal of Dermatological Science, ISSN: 0923-1811, Vol: 16, Issue: 2, Page: 144-151
1998
- 84Citations
- 40Captures
- 2Mentions
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations84
- Citation Indexes84
- 84
- CrossRef71
- Captures40
- Readers40
- 40
- Mentions2
- References2
- Wikipedia2
Article Description
We have studied the growth kinetics of fibroblasts derived from uninjured skin and chronic wounds in non-diabetic and diabetic (IDDM) patients. DNA measurements during the first 24 h after cell starvation showed that fibroblasts derived from chronic wounds, both non-diabetic and diabetic, display a decreased adhesion and proliferation. When determining the rate of proliferation after another 48, 72 and 96 h, a significant decrease in the proliferation rate was found in the chronic wound fibroblasts compared to those from uninjured skin. Furthermore, we have investigated the effects of heparin, hyaluronic acid and other heparin-like substances on the proliferation of non-diabetic and diabetic fibroblasts. We found that these substances stimulated the proliferation of human fibroblasts derived from both normal skin and chronic wounds measured as DNA content. Stimulation with heparin normalized the proliferation of the diabetic chronic wound fibroblasts. This effect was independent of the presence of serum. The effect of heparin was dose-dependent and most pronounced during the first 24 h of stimulation. These results suggest that heparin may be of importance in the treatment of chronic diabetic wounds.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S092318119700042X; http://dx.doi.org/10.1016/s0923-1811(97)00042-x; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=0030635250&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/9459127; http://linkinghub.elsevier.com/retrieve/pii/S092318119700042X; http://api.elsevier.com/content/article/PII:S092318119700042X?httpAccept=text/xml; http://api.elsevier.com/content/article/PII:S092318119700042X?httpAccept=text/plain; https://linkinghub.elsevier.com/retrieve/pii/S092318119700042X; http://dx.doi.org/10.1016/s0923-1811%2897%2900042-x; https://dx.doi.org/10.1016/s0923-1811%2897%2900042-x
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know